REQUEST A DEMO
Total
USD $0.00
Search more companies

Medchoice Endocrine Group, Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Medchoice Endocrine Group, Inc. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medchoice Endocrine Group, Inc. is an enterprise located in Philippines, with the main office in Not Disclosed. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on July 30, 2013. There was a net sales revenue increase of 16.71% reported in Medchoice Endocrine Group, Inc.’s latest financial highlights for 2023. There was a total growth of 25.9% in Medchoice Endocrine Group, Inc.’s total assets over the same period. In 2023, Medchoice Endocrine Group, Inc.’s net profit margin increased by 0.15%.

Headquarters
Not Disclosed
Not Disclosed; Not Disclosed;

Contact Details: Purchase the Medchoice Endocrine Group, Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Medchoice Endocrine Group, Inc. report to view the information.
Incorporation Date:
July 30, 2013
Company Performance
Financial values in the chart are available after Medchoice Endocrine Group, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
16.71%
Total operating revenue
16.71%
Operating profit (EBIT)
18.41%
EBITDA
18.41%
Net Profit (Loss) for the Period
17.35%
Total Assets
25.9%
Total Equity
115.39%
Operating Profit Margin (ROS)
0.51%
Net Profit Margin
0.15%
Return on Equity (ROE)
-79.46%
Debt/Equity
-109.53%
Quick Ratio
0.26%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?